BCL2 and lymphoma: Bcl2 is an antiapoptotic protein; while its rearrangement is typically seen in FCL, some DLBCL and double/triple hit lymphomas, Bcl2 is also widely and differentially expressed in other B-NHL lacking t(11;14), including CLL and MZL [34,35,36,37].